These results indicated that inhibition of FOXO1 may contribute to the development of ICC, and CCL18/PITPNM3 axis can promote the proliferation, migration, and invasion of ICC by regulating FOXO1 signaling pathway. The gene discussed is CCL18; the disease is intrahepatic cholangiocarcinoma.